The United States and Canada are the leading countries in this market, with a competitive landscape featuring key players such as Lonza and Aceto Corporation
A randomized, double-blind, placebo-controlled trial reported a significant reduction in melanin indices after four weeks of supplementation with 500 mg/day, particularly in sun-exposed areas [12]
doi: 10.3390/ijms18010168 201 SamadMBMohsinMRazuBAHossainMTMahzabeenSUnnoorNet al
If stable disease after 12 months peptide use, trial 3-month break to see if benefits sustained, resume if progression resumes
And perhaps most important, was the test done at a time where the gastrointestinal tract still suffered from lack of B12, and because of that had a temporary decreased capacity for uptake of B12
If you're conducting a short-term experiment with injectable administration where the peptide will be used within a day or two of reconstitution, the standard acetate form may be perfectly sufficient and more cost-effective